King Charles III’s cancer treatment is expected to proceed into 2025, longer than initially anticipated. The 76-year-old monarch was diagnosed in February 2024 and has been under continuous medical care since then.
While the announcement recognizes some progression, it affirms the sustained nature of his illness. Palace sources noted, “Treatment has been moving in a positive direction, and as a managed condition, the treatment cycle will continue into next year.”
After a three-night stay at the London Clinic due to an enlarged prostate in January, King Charles III was initially diagnosed. During the procedure, a separate health issue was discovered, which led to further diagnostic tests and ultimately revealed cancer. Charles started his cancer treatments on February 5, temporarily retreating from public duties.
Despite his diagnosis, Charles has gradually returned to public life since April 2024. He has hosted international dignitaries, such as the Amir of Qatar, and conducted a royal tour to Australia and Samoa with Queen Camilla in October. A senior palace official commented, “We’re now working on a pretty normal-looking, full overseas tour program for next year, which is a high for us to end on, to know that we can be thinking in those terms, subject to sign off by doctors.”
In June 2024, Charles proved his resilience by attending D-Day commemorations in Normandy, France, his first international engagement since diagnosis. He also took part in the traditional Trooping the Colour ceremony, upholding important royal traditions amidst his ongoing treatment.
Dame Laura Lee, Maggie’s Cancer Support Charity’s chief executive, clarified the prolonged treatment plan, saying, “It’s very common for treatment to be ongoing for very long periods of time… We’ve got immunotherapy, chemotherapy, surgery, hormone therapy. There are all sorts of different treatment modalities.”
The diagnosis of the King occurred during a tough year for the royal family. His daughter-in-law, Kate Middleton, the Princess of Wales, announced her own cancer diagnosis in March 2024. The 42-year-old princess completed her chemotherapy treatment in September. Prince William referred to 2024 as “probably the hardest year” of his life, dealing with the health issues of both his wife and father.
Former U.S. President Donald Trump offered a rare insight into the monarch’s private battle, disclosing the King is “fighting very hard” against the disease.
Adding to the health issues of the royal family, Queen Camilla, 77, recently missed several events due to a chest infection, further affecting the palace’s ability to function normally.
While managing treatment side effects such as the loss of taste, the King continues his adjusted schedule of duties. Despite these hurdles, Charles maintained a busy December schedule, hosting the annual royal family Christmas lunch on December 19 and visiting Walthamstow, East London, with Queen Camilla on December 20 to endorse community initiatives.
Healthcare professionals across the UK have responded positively to the monarch’s recognition of their work. Dr. Sarah Mitchell, a consultant at St. Thomas’ Hospital in London, views the King’s message as a powerful acknowledgment of healthcare workers’ daily challenges. “Having such high-profile recognition helps remind everyone of the essential role medical professionals play in all our lives, regardless of status,” she noted.
The King’s appearance at Sandringham’s Christmas Day service, where he greeted well-wishers alongside other royal family members, demonstrated the practical impact of the medical care he praised. The traditional walk to St. Mary Magdalene Church took on added significance this year, serving as a visible testament to the success of his medical treatment.
